Celiprolol hydrochloride

CAS No. 57470-78-7

Celiprolol hydrochloride( Corliprol | NSC 324509 )

Catalog No. M15097 CAS No. 57470-78-7

A cardioselective beta-1 adrenergic antagonist that has intrinsic symopathomimetic activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Celiprolol hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    A cardioselective beta-1 adrenergic antagonist that has intrinsic symopathomimetic activity.
  • Description
    A cardioselective beta-1 adrenergic antagonist that has intrinsic symopathomimetic activity.
  • In Vitro
    Celiprolol hydrochloride (0-3 mM, 90 min) is uptaken by human small intestinal transporter OATP-A/1A2 in Xenopus Laevis oocytes.Celiprolol hydrochloride (10 μM, 0-50 min) is transported across human intestinal epithelial (Caco-2) cells by mediation of multiple transporters including P-glycoprotein.
  • In Vivo
    Celiprolol hydrochloride (Oral administration, 100 mg/kg/day for 31 days) improves endothelial function in the arteries of in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, and restores it 4 weeks after endothelial denudation in the arteries of OLETF rats.Celiprolol hydrochloride (Treated in drinking water, 10 mg/kg/day for 5 weeks) suppresses VCAM-1 expression by inhibition of oxidative stress, NF-κB, signal transduction, and increases eNOS via stimulation of the PI3K-Akt pathway, and improves cardiovascular remodeling in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Animal Model:Type II male Otsuka Long-Evans Tokushima Fatty (OLETF) diabetic rats Dosage:100 mg/kg/day for 31 days Administration:Oral administration Result:Improved acetylcholine-induced NO-dependent relaxation in arteries.Improved tone-related basal NO release and acetylcholine-induced NO-dependent relaxation in the arteries and plasma NOx.Animal Model:Deoxycorticosterone acetate (DOCA)-salt hypertensive rats Dosage:10 mg/kg/d for 5 weeks Administration:Treated in drinking water Result:Activated phosphorylation of eNOS through the PI3K-Akt signaling pathway.Modulated VCAM-1 expression, which is associated with inhibition of NF-κB phosphorylation.Reduced production of ROS by suppressing NAD(P)H oxidase subunit p22phox, p47phox, gp91phox, and nox1 expression.
  • Synonyms
    Corliprol | NSC 324509
  • Pathway
    Endocrinology/Hormones
  • Target
    Adrenergic Receptor
  • Recptor
    β-adrenergic receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    57470-78-7
  • Formula Weight
    415.96
  • Molecular Formula
    C20H33N3O4·HCl
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    Cl.CCN(CC)C(=O)NC1=CC(C(C)=O)=C(OCC(O)CNC(C)(C)C)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Abdelkrim MA, et al. Can J Physiol Pharmacol. 2013 Oct;91(10):791-6.
molnova catalog
related products